BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2368791)

  • 1. Pulmonary diffusing capacity disturbances are related to nailfold capillary changes in patients with Raynaud's phenomenon with and without an underlying connective tissue disease.
    Groen H; Wichers G; ter Borg EJ; van der Mark TW; Wouda AA; Kallenberg CG
    Am J Med; 1990 Jul; 89(1):34-41. PubMed ID: 2368791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early detection of connective tissue disease in patients with Raynaud's phenomenon.
    Kallenberg CG
    Rheum Dis Clin North Am; 1990 Feb; 16(1):11-30. PubMed ID: 2406802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of nailfold capillary abnormalities in patients with connective tissue diseases.
    Ohtsuka T
    Int J Dermatol; 1999 Oct; 38(10):757-64. PubMed ID: 10561047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The predictive value of quantitative nailfold capillary microscopy in patients with undifferentiated connective tissue disease.
    Ohtsuka T; Tamura T; Yamakage A; Yamazaki S
    Br J Dermatol; 1998 Oct; 139(4):622-9. PubMed ID: 9892906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial nailfold capillary microscopy in primary Raynaud's phenomenon and scleroderma.
    ter Borg EJ; Piersma-Wichers G; Smit AJ; Kallenberg CG; Wouda AA
    Semin Arthritis Rheum; 1994 Aug; 24(1):40-7. PubMed ID: 7985036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased nailfold capillary density in Raynaud's phenomenon: a reflection of immunologically mediated local and systemic vascular disease?
    Houtman PM; Kallenberg CG; Wouda AA; The TH
    Ann Rheum Dis; 1985 Sep; 44(9):603-9. PubMed ID: 4037886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary function in systemic lupus erythematosus is related to distinct clinical, serologic, and nailfold capillary patterns.
    Groen H; ter Borg EJ; Postma DS; Wouda AA; van der Mark TW; Kallenberg CG
    Am J Med; 1992 Dec; 93(6):619-27. PubMed ID: 1466357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relation between nailfold bleeding and capillary microscopic abnormality in patients with connective tissue diseases.
    Ohtsuka T
    Int J Dermatol; 1998 Jan; 37(1):23-6. PubMed ID: 9522233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic significance of nailfold capillary patterns in patients with Raynaud's phenomenon. An analysis of patterns discriminating patients with and without connective tissue disease.
    Houtman PM; Kallenberg CG; Fidler V; Wouda AA
    J Rheumatol; 1986 Jun; 13(3):556-63. PubMed ID: 3735277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scleroderma-like nailfold capillaroscopic abnormalities are associated with anti-U1-RNP antibodies and Raynaud's phenomenon in SLE patients.
    Furtado RN; Pucinelli ML; Cristo VV; Andrade LE; Sato EI
    Lupus; 2002; 11(1):35-41. PubMed ID: 11899953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease.
    Maricq HR; Harper FE; Khan MM; Tan EM; LeRoy EC
    Clin Exp Rheumatol; 1983; 1(3):195-205. PubMed ID: 6335855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digital blood flow and nailfold capillary microscopy in Raynaud's phenomenon.
    Lee P; Sarkozi J; Bookman AA; Keystone EC; Armstrong SK
    J Rheumatol; 1986 Jun; 13(3):564-9. PubMed ID: 3735278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study of the evolution of Raynaud's phenomenon.
    Fitzgerald O; Hess EV; O'Connor GT; Spencer-Green G
    Am J Med; 1988 Apr; 84(4):718-26. PubMed ID: 3261127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raynaud's features in childhood. Clinical, immunological and capillaroscopic study.
    Navon P; Yarom A; Davis E
    J Mal Vasc; 1992; 17(4):273-6. PubMed ID: 1494054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic factors in Raynaud's phenomenon: usefulness of antinuclear antibodies and of periungual capillaroscopy].
    Passiu G; Sebastiani GD; Galeazzi M; Tuveri MA; Nicosia PM; Boirivant R
    Medicina (Firenze); 1990; 10(4):405-7. PubMed ID: 2099984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased nailfold capillary dimensions in primary Raynaud's phenomenon and systemic sclerosis.
    Bukhari M; Herrick AL; Moore T; Manning J; Jayson MI
    Br J Rheumatol; 1996 Nov; 35(11):1127-31. PubMed ID: 8948300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nailfold capillaroscopy in connective tissue disorders and in Raynaud's phenomenon.
    Blockmans D; Vermylen J; Bobbaers H
    Acta Clin Belg; 1993; 48(1):30-41. PubMed ID: 8388601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease.
    Gerbracht DD; Steen VD; Ziegler GL; Medsger TA; Rodnan GP
    Arthritis Rheum; 1985 Jan; 28(1):87-92. PubMed ID: 3871330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolution of Raynaud's phenomenon: a longterm prospective study.
    Luggen M; Belhorn L; Evans T; Fitzgerald O; Spencer-Green G
    J Rheumatol; 1995 Dec; 22(12):2226-32. PubMed ID: 8835553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary function in patients presenting with Raynaud's phenomenon without an underlying connective tissue disease. A prospective, longitudinal study.
    Aalbers R; Groen H; Postma DS; Van der Mark TW; Wouda AA; Reig RP; Kallenberg CG
    J Rheumatol; 1989 Jan; 16(1):36-41. PubMed ID: 2785598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.